Variant report
Variant | esv3348954 |
---|---|
Chromosome Location | chr2:209500632-209503055 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs577911622 | chr2:209500662-209500663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189001732 | chr2:209500670-209500671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543364235 | chr2:209500786-209500787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs13024405 | chr2:209500788-209500789 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs550092961 | chr2:209500800-209500801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs1429879 | chr2:209500802-209500803 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs151165487 | chr2:209500820-209500821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559058386 | chr2:209500823-209500824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs34877536 | chr2:209500834-209500835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs397873204 | chr2:209500836-209500837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572728928 | chr2:209500846-209500847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545034171 | chr2:209500868-209500869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs139163181 | chr2:209500876-209500877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531194271 | chr2:209500978-209500979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551299716 | chr2:209501015-209501016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374887793 | chr2:209501032-209501033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75545342 | chr2:209501033-209501034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541151193 | chr2:209501051-209501052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530331549 | chr2:209501060-209501061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547097638 | chr2:209501109-209501110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181040399 | chr2:209501229-209501230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187167193 | chr2:209501295-209501296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191137155 | chr2:209501306-209501307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs569163208 | chr2:209501316-209501317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144012526 | chr2:209501322-209501323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181976241 | chr2:209501328-209501329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577779392 | chr2:209501339-209501340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144109408 | chr2:209501347-209501348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544869358 | chr2:209501361-209501362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs16841506 | chr2:209501364-209501365 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs570852225 | chr2:209501369-209501370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146472735 | chr2:209501381-209501382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565850066 | chr2:209501383-209501384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs572933084 | chr2:209501443-209501444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12477695 | chr2:209501456-209501457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12477763 | chr2:209501457-209501458 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs185990454 | chr2:209501464-209501465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544883254 | chr2:209501475-209501476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs199584388 | chr2:209501487-209501488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561599878 | chr2:209501495-209501496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs377187035 | chr2:209501503-209501504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149744254 | chr2:209501518-209501519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190660603 | chr2:209501519-209501520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200537106 | chr2:209501526-209501527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs201814062 | chr2:209501527-209501528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs12469676 | chr2:209501529-209501530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546727808 | chr2:209501535-209501536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547257156 | chr2:209501536-209501537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560531866 | chr2:209501537-209501538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374134179 | chr2:209501542-209501543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:209494600-209502400 | Weak transcription | K562 | blood |
2 | chr2:209495000-209512800 | Weak transcription | Fetal Kidney | kidney |
3 | chr2:209502400-209503400 | Enhancers | K562 | blood |
4 | chr2:209502800-209503600 | Enhancers | Fetal Intestine Large | intestine |
5 | chr2:209503000-209503400 | Enhancers | Fetal Intestine Small | intestine |